<i>In Vitro</i>Selection of Variants Resistant to β-Lactams plus β-Lactamase Inhibitors in CTX-M β-Lactamases: Predicting the<i>In Vivo</i>Scenario?
Aída Ripoll(Instituto Cajal), Juan Carlos Galán(Instituto Ramón y Cajal de Investigación Sanitaria), Rafael Cantón(Instituto Ramón y Cajal de Investigación Sanitaria), Ângela Novais(Universidade do Porto), Fernando Baquero(Instituto Cajal), Mario Rodríguez-Domínguez(Instituto Cajal), María-Carmen Turrientes(Instituto Ramón y Cajal de Investigación Sanitaria)
Cited by 46
Related Papers
Defining and combating antibiotic resistance from One Health and Global Health perspectives
|Nature Microbiology|2019|1.2k
The CTX-M β-lactamase pandemic
|Current Opinion in Microbiology|2006|1.1k
What is a resistance gene? Ranking risk in resistomes
|Nature Reviews Microbiology|2014|1k
CTX-M Enzymes: Origin and Diffusion
|Frontiers in Microbiology|2012|955
CTX-M: changing the face of ESBLs in Europe
|Journal of Antimicrobial Chemotherapy|2006|923